#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma recurrent Dermatomyositis Kawasaki's disease Systemic sclerosis pulmonary Glomerulonephritis chronic Peripheral T-cell lymphoma unspecified Sickle cell anaemia Gastrointestinal disorder Pyoderma gangrenosum Pleural mesothelioma Ewing's sarcoma recurrent Kearns-Sayre syndrome Frontotemporal dementia Antisynthetase syndrome Follicle centre lymphoma follicular grade I II – III refractory More trials…

    Learn about Rare Diseases

    Alexander disease – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Hepatoblastoma – Basic Information Hereditary motor and sensory neuropathy – Diagnostics Crigler-Najjar syndrome – Life with Disease Ehlers-Danlos syndrome – Basic Information Small intestine leiomyosarcoma Phenylketonuria Ornithine transcarbamoylase deficiency – Basic Information Pelizaeus-Merzbacher disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Opium, Standardized Powdered Lacutamab Pf-06480605 Depemokimab Peposertib Abc-35B-116 Entrectinib Ziprasidone Valproic Acid Agrostis Stolonifera Pollen GUAIACOL Miglustat VOROLANIB Neratinib Nmd670 Orismilast Gozetotide Ublituximab Adrc Salmeterol More therapies…

    Learn about Your Condition

    Vaginal haemorrhage Macular telangiectasia Corneal graft rejection Myeloproliferative neoplasm Open angle glaucoma Intracranial calcification Vulvovaginal pain Dent's disease Breast cancer Thrombolysis Small intestine carcinoma Pain Nocturia Diabetic retinopathy Prostate cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Safety and Effectiveness of IMA402, Tocilizumab, and Human Serum Albumin for Patients with Recurrent or Resistant Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Ima402
    • IMA401
    • Human Serum Albumin
    Germany The Netherlands

  • Study on [68Ga]Ga-PentixaFor PET Imaging for Better Risk and Disease Assessment in Patients with Multiple Myeloma

    Recruiting

    1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Pentixafor
    • Gallium (68Ga)
    Belgium The Netherlands

  • Phase III Trial Comparing ABVD vs A2VD Treatment With PET-Guided Radiation Therapy for Patients With Early Stage Hodgkin Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Bleomycin
    • Brentuximab Vedotin
    • Vinblastine Sulfate
    Belgium Denmark Ireland The Netherlands Portugal Slovakia +1

  • Study of Tebentafusp and Pembrolizumab for Patients with Previously Treated Advanced Melanoma

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Tebentafusp
    • Dexamethasone Phosphate
    • Diphenhydramine
    Austria Belgium France Germany Italy Poland +1

  • Study on INTESTIFIX for Maintaining Remission in Children and Adults with Crohn’s Disease After Exclusive Enteral Nutrition Treatment

    Recruiting

    1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Intestifix
    Germany

  • Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

    Recruiting

    3 1
    Investigated Diseases:
    • Exfoliation glaucoma
    • Pigmentary glaucoma
    • Open angle glaucoma
    Investigated Drugs:
    • Citicoline Sodium
    Belgium France Greece Hungary Italy Poland +1
Previous Page
1 … 595 596 597 598 599 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!